Table 2 The imaging characteristics before and after treatment between the Tet group and the control group

Samll nodule [M(P25, 75)]

 Before administration

6.0(4.0, 8.0)

7.5(4.0, 10.0)

0.120

 After administration

6.0(4.0, 8.0)

7.5(4.0, 10.0)

0.046

P -Value

0.206

0.710

PMF size [M(P25, 75)]

 Before administration

1568.0(682.0, 2905.0)

2055.0(904.0, 2070.0)

0.790

 After administration

1526.0(758.0, 2528.0)

2306.0(1243.0, 3722.0)

0.001

P -Value

0.210

0.000

Emphysema [M(P25, 75)]

 Before administration

6.0 (6.0, 11.3)

8.0 (6.0, 18.0)

0.035

 After administration

6.0 (6.0, 11.8)

12.0 (6.0, 18.0)

0.022

P -Value

0.059

0.016

Rate of increase in PMF size [M(P25, 75)]

-2.5(-26.3, 11.8)

21.9(5.81, 39.9)

0.001

Patients with stable PMF n(%)

40(70)

23(32.8)

Patients with progression PMF n(%)

17(30)

47(67.2)

0.000